iOnctura starts Phase II study in metastatic uveal melanoma
20 Mar 2025 //
PR NEWSWIRE
iOnctura announces expansion of roginolisib clinical trial program to NSCLC
09 Jul 2024 //
PR NEWSWIRE
20 Mar 2025 //
PR NEWSWIRE
09 Jul 2024 //
PR NEWSWIRE